The Regulation of Macropinocytosis

巨胞饮作用的调节

基本信息

  • 批准号:
    10598550
  • 负责人:
  • 金额:
    $ 45.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Abstract: Macropinosomes are relatively large endocytic vesicles which form in nearly all growing metazoan cells by movements of plasma membrane and the actin cytoskeleton, and which deliver extracellular solutes into lysosomes by microtubule-dependent membrane fusion reactions. Macropinocytosis is the route by which many pathogenic bacteria and viruses invade host cells, antigen is sampled for initiation of immune responses, and extracellular nutrients are ingested to support the growth of K-Ras-transformed cancer cells. Research in the Swanson lab has introduced foundational concepts about macropinocytosis, including how membrane phospholipid-modifying enzymes and cytoskeletal activities coordinate macropinosome formation, how macropinosomes transmit growth signals from cell surface receptors to the mechanistic target of rapamycin complex-1 (mTORC1) on lysosomal membranes, and how macropinocytosis limits damage to lysosomal membranes in activated macrophages. Despite the recognized importance of macropinocytosis in health and disease, and the considerable progress in understanding its mechanism and regulation, significant questions remain unanswered: (1) How does type 1 phosphatidylinositol 3-kinase organize macropinocytic cup closure into macropinosomes? (2) How do Src-family kinases regulate macropinocytosis? (3) What molecules or activities determine whether macropinosomes deliver their solute contents into lysosomes or recycle them to the cell surface? (4) How does cellular nutrient status influence solute accumulation by macropinocytosis? This research program uses innovative approaches to cell biology, molecular genetics and quantitative microscopy to answer these fundamental questions. The continuation of this research will put macropinocytosis into the context of cell growth, metabolism and innate immunity, and could lead to new therapeutic approaches to cancer, infectious diseases and disorders of the immune system.
文摘:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOEL A SWANSON其他文献

JOEL A SWANSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOEL A SWANSON', 18)}}的其他基金

The Regulation of Macropinocytosis
巨胞饮作用的调节
  • 批准号:
    9893006
  • 财政年份:
    2019
  • 资助金额:
    $ 45.87万
  • 项目类别:
The Regulation of Macropinocytosis
巨胞饮作用的调节
  • 批准号:
    10784227
  • 财政年份:
    2019
  • 资助金额:
    $ 45.87万
  • 项目类别:
The Regulation of Macropinocytosis
巨胞饮作用的调节
  • 批准号:
    10372920
  • 财政年份:
    2019
  • 资助金额:
    $ 45.87万
  • 项目类别:
The Regulation of Macropinocytosis
巨胞饮作用的调节
  • 批准号:
    9330196
  • 财政年份:
    2014
  • 资助金额:
    $ 45.87万
  • 项目类别:
The Regulation of Macropinocytosis
巨胞饮作用的调节
  • 批准号:
    8670202
  • 财政年份:
    2014
  • 资助金额:
    $ 45.87万
  • 项目类别:
Imaging 3' phosphoinositides in vivo
体内 3 磷酸肌醇成像
  • 批准号:
    8821717
  • 财政年份:
    2014
  • 资助金额:
    $ 45.87万
  • 项目类别:
The Regulation of Macropinocytosis
巨胞饮作用的调节
  • 批准号:
    9128667
  • 财政年份:
    2014
  • 资助金额:
    $ 45.87万
  • 项目类别:
The Regulation of Macropinocytosis
巨胞饮作用的调节
  • 批准号:
    8921225
  • 财政年份:
    2014
  • 资助金额:
    $ 45.87万
  • 项目类别:
Inducible Renitence in Macrophages
巨噬细胞中的诱导性记忆
  • 批准号:
    8723245
  • 财政年份:
    2013
  • 资助金额:
    $ 45.87万
  • 项目类别:
Inducible Renitence in Macrophages
巨噬细胞中的诱导性记忆
  • 批准号:
    8852635
  • 财政年份:
    2013
  • 资助金额:
    $ 45.87万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.87万
  • 项目类别:
    Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
    Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
    Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 45.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了